Elon's New A.I. Device is About to Shock the World

Gold Is Beating Stocks-Here's What That Means for You....

This Gold Penny Stock Is Backed by a Who's Who of Legends One of the biggest names in gold recently added millions of shares of a little-known U.S. gold miner. He now owns over 7 million shares-and he's not alone. The founder of Goldcorp owns a sizable stake. The man behind Kinross sits on the board. These are serious insiders with a long track record of gold success. And they're betting on what might be the next major U.S. gold story. Find out which gold play is catching the attention of the big guns.

This message is a paid advertisement sent on behalf of i2i Marketing Group, LLC., a third-party advertiser of TraderEliteClub. This message is a paid advertisement for Defence Therapeutics (DTCFF) from i2i Marketing Group, LLC. TraderEliteClub receives a fixed fee for each subscriber that clicks on a link in this email, totaling up to $1500.00 USD. Other than the compensation received for this advertisement sent to subscribers, TraderEliteClub and its principals are not affiliated with i2i Marketing Group, LLC..TraderEliteClub and its principals do not own any of the stocks mentioned in this email or in the article that this email links to. Neither TraderEliteClub nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from TraderEliteClub to buy or sell any security. TraderEliteClub has not evaluated the accuracy of any claims made in this advertisement. TraderEliteClub recommends that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky. Past-performance is not indicative of future results. Please see the disclaimer regarding Defence Therapeutics (DTCFF) on i2i Marketing Group, LLC. website for additional information about the relationship between i2i Marketing Group, LLC. and Defence Therapeutics (DTCFF). Information, charts, or examples contained in this email are for illustration and educational purposes only and not for individualized investment management. This message contains commercial elements, such as advertising and partner offers for which we may receive affiliate compensation. We only send these offers to those who have opted into our newsletter. If you wish to no longer receive these offers, click on the unsubscribe link at the bottom of this email. Past performance is not indicative of future results. For these reasons, we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices, or procedures of any company or entity mentioned or recommended in this email and have not determined if the statements and opinions of the advertiser are accurate, correct, or truthful. If you use, act upon, or make decisions in reliance on information contained in this email or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates, and agents without fault. 2967 Dundas St. W. #990, Toronto, ON M6P 1Z2 | Phone Number: 917.672.7040 © 2025 Musth | TraderEliteClub | All rights reserved. UNSUBSCRIBE